Andrew Willis

ORCID: 0000-0002-9671-2162
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Crime Patterns and Interventions
  • Crime, Illicit Activities, and Governance
  • Diabetes Management and Education
  • Criminal Justice and Corrections Analysis
  • Ethics in Clinical Research
  • Cinema History and Criticism
  • Cybercrime and Law Enforcement Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Disease Management Strategies
  • Policing Practices and Perceptions
  • Spanish Culture and Identity
  • Palliative Care and End-of-Life Issues
  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Homelessness and Social Issues
  • Wildlife Conservation and Criminology Analyses
  • Crime, Deviance, and Social Control
  • Social Media in Health Education
  • Health Systems, Economic Evaluations, Quality of Life
  • Global Public Health Policies and Epidemiology
  • Patient-Provider Communication in Healthcare
  • Sex and Gender in Healthcare
  • Terrorism, Counterterrorism, and Political Violence
  • Health Services Management and Policy
  • Health Promotion and Cardiovascular Prevention

University of Leicester
2009-2024

University College Cork
2023-2024

Atrium Health Wake Forest Baptist
2023

Leicester General Hospital
2020-2022

NIHR Clinical Research Network
2016-2022

ORCID
2022

National Institute for Health Research
2020

University of Glasgow
2019

NIHR Applied Research Collaboration Greater Manchester
2016

University of Salford
2004-2014

Risk factors for cardiovascular disease including diabetes have seen a large rise in prevalence recent years. This has prompted interest prevention through the identifying individuals at risk of both and increased investment screening interventions taking place primary care. Community pharmacies become increasingly involved provision such this systematic review meta-analysis aims to gather analyse existing literature assessing community pharmacy based those with high risk. Methods We...

10.1371/journal.pone.0091157 article EN cc-by PLoS ONE 2014-04-01

Randomised trials, especially those intended to directly inform clinical practice and policy, should be designed reflect all who could benefit from the intervention under test it prove effective. This does not always happen. The UK National Institute for Health Care Research (NIHR) INCLUDE project identified many groups in that are under-served by including ethnic minorities.This guidance document presents four key recommendations designing running trials include needed trial. These (1)...

10.1186/s13063-022-06553-w article EN cc-by Trials 2022-08-17

The COVID-19 pandemic has brought into focus issues of health inequality and the disproportionate disease burden experienced by ethnic minority communities, compared with population as a whole.1Khunti K Singh AK Pareek M Hanif W Is ethnicity linked to incidence or outcomes COVID-19?.BMJ. 2020; 369m1548Crossref PubMed Scopus (253) Google Scholar High-quality research is basis for an evidence-based approach delivery care. It widely accepted that some subgroups patients might respond...

10.1016/s2468-2667(21)00100-6 article EN cc-by-nc-nd The Lancet Public Health 2021-06-24

Abstract Background Barriers to mental health research participation are well documented including distrust of services and research; stigma surrounding health. They can contribute a lack diversity amongst participants in research, which threatens the generalisability knowledge. Given recent widespread use internet medical this study aimed explore perspectives key partners on online (e.g. social media) offline in-person) recruitment as an approach improving randomised controlled trials...

10.1186/s12874-023-02032-1 article EN cc-by BMC Medical Research Methodology 2023-09-21

It is important to design clinical trials include all those who may benefit from the intervention being tested. Several frameworks have been developed help researchers think about barriers inclusion of particular under-served groups when designing a trial, but there lack practical guidance on how implement these frameworks. This paper describes ACCESS project, findings each phase project and we (STEP UP) more inclusive trials.

10.1186/s12874-024-02342-y article EN cc-by BMC Medical Research Methodology 2024-10-02

Ethnic minority populations experience significant health and social care disparities; despite experiencing a greater burden of diseases, these groups are underrepresented in research. Consequently, related research can be less applicable to population groups. The REPRESENT study aims explore the experiences ethnic minorities other minoritised populations, their interests appropriate practices.

10.1111/hex.13944 article EN cc-by Health Expectations 2023-12-21

Participants in clinical trials often do not reflect the populations that could benefit from treatments being investigated. There are known barriers to trial participation for under-served groups, but limited evidence on strategies alleviate these improve representation. This scoping review aimed identify effective interventions and design features representation `of groups trials, focusing UK Ireland.

10.3310/nihropenres.13524.1 article EN cc-by NIHR Open Research 2024-03-25

In the development of police officer authoritarianism, importation variables do not appear decisive. Police recruit authoritarianism is no different from that fire service recruits with a similar background. Initial training, however, depresses despite unambiguous emphasis in training on law and discipline. Finally, experience on‐the‐beat policing leads to dramatic increase traditionally policed area high crime rate, but low rate an community policing.

10.1111/j.2044-8325.1985.tb00185.x article EN Journal of Occupational Psychology 1985-06-01

10.1057/palgrave.sj.8340128 article EN Security Journal 2003-01-01

10.1136/bmj.2.5474.1333 article EN BMJ 1965-12-04

This study is one of a series designed to determine the optimum dose antitoxin in tetanus. Each was allotted at random patients after diagnosis. With sequential analysis, trial stopped 270 had been treated. It concluded that lower least as effective higher.

10.1002/cpt196565592 article EN Clinical Pharmacology & Therapeutics 1965-09-01
Coming Soon ...